Biologic Therapeutic Drug Market
Biologic Therapeutic Drug Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Biologic Therapeutic Drug Market Size and Growth
The Biologic Therapeutic Drug market is experiencing significant growth, driven by increasing demand for innovative treatments. As of 2023, the market size is estimated at approximately $300 billion, with a projected CAGR of 8% through 2030. Factors influencing market conditions include advancing technologies, expanding indications, and regulatory support. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Aurobindo Pharma Ltd.
◍ Concord Biotech
◍ GlaxoSmithKline Plc.
◍ H. Lundbeck A/S
◍ Novartis Global
◍ Retractable Technologies, Inc.
◍ Smith Medical
◍ AstraZeneca
◍ Pfizer Inc.
◍ Merck and Co. Inc.
The Biologic Therapeutic Drug Market features major players like Aurobindo Pharma, GlaxoSmithKline, Novartis, and Pfizer, focusing on innovative treatments. Companies conduct R&D, partnerships, and commercialization strategies to expand market reach.
Notable revenue includes Pfizer's $41.9 billion and Novartis' $48.3 billion, contributing significantly to market growth. Request Sample Report
Market Segmentation
By Application
Clinical Medicine
Laboratory
Others
Request Sample Report
By Product
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Market Growth
Request Sample Report
$ X Billion USD
